Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Depreciation & Amortization (CF): 2009-2025

Historic Depreciation & Amortization (CF) for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $24.3 million.

  • BIO-TECHNE's Depreciation & Amortization (CF) fell 13.49% to $24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.1 million, marking a year-over-year decrease of 4.67%. This contributed to the annual value of $109.9 million for FY2025, which is 1.62% down from last year.
  • BIO-TECHNE's Depreciation & Amortization (CF) amounted to $24.3 million in Q3 2025, which was down 10.22% from $27.1 million recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's Depreciation & Amortization (CF) registered a high of $28.5 million during Q3 2023, and its lowest value of $21.1 million during Q1 2021.
  • In the last 3 years, BIO-TECHNE's Depreciation & Amortization (CF) had a median value of $27.3 million in 2024 and averaged $27.3 million.
  • Per our database at Business Quant, BIO-TECHNE's Depreciation & Amortization (CF) climbed by 20.21% in 2022 and then dropped by 13.49% in 2025.
  • BIO-TECHNE's Depreciation & Amortization (CF) (Quarterly) stood at $25.1 million in 2021, then increased by 6.38% to $26.7 million in 2022, then grew by 4.12% to $27.8 million in 2023, then declined by 2.59% to $27.1 million in 2024, then dropped by 13.49% to $24.3 million in 2025.
  • Its last three reported values are $24.3 million in Q3 2025, $27.1 million for Q2 2025, and $27.6 million during Q1 2025.